Expanding access to naloxone, sterile syringes, and HIV preexposure prophylaxis can help prevent negative consequences of drug use and reduce inequities in overdose-related morbidity and mortality.
This nonopioid veterinary tranquilizer, which is not approved for human use, is linked to an alarming number of drug overdose deaths across the United States.
Researchers suggest that measures aimed at improving mood could reduce inflammation and potentially provide an alternative treatment or one that works alongside inflammatory bowel disease medications.
Multidisciplinary collaboration coupled with the use of multimodal strategies has enabled the tailoring of treatment plans based on the patient’s medical status and type of surgery.